Vivasure Medical Ltd. received CE mark approval for its Perqseal Elite vascular closure system which manages bleeding complications associated with large-bore arterial vessel closure. The sutureless, ...

Discover NovoCure's Q1 2025 earnings insights, including Optune Lua's NSCLC progress, global market growth, and strong revenue performance.

Optune Lua received a CE Mark for metastatic non–small cell lung cancer with immune checkpoint inhibitors or docetaxel.

Vivasure Medical has received CE mark approval for its PerQseal Elite vascular closure system, providing a new bioresorbable ...

NEW YORK – Roche announced on Wednesday that it has received CE marking for its Chest Pain Triage algorithm to help rule in and rule out heart attacks in the emergency department.

The data from the Phase III LUNAR trial, which assessed the device’s treatment efficacy and safety, supported the approval.